Normal Glypican-3 Serum Levels Do Not Eliminate the Risk of Hepatocellular Carcinoma
Introduction. Hepatocellular carcinoma (HCC) is a malignancy that primarily affects patients with liver cirrhosis. Early diagnosis is crucial for improving patient outcomes. The study aimed to investigate the potential role of glypican-3 (GPC3) serum levels, both alone and in combination with alp...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ivano-Frankivsk National Medical University
2024-09-01
|
| Series: | Galician Medical Journal |
| Subjects: | |
| Online Access: | https://ifnmujournal.com/gmj/article/view/1965 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|